Compare · head to head
Hanall Biopharma vs Kukje Pharma
Kukje Pharma ranks higher overall — 360 rank 43 vs 30.
Kukje Pharma leads on Value (50 vs 40) and Quality (60 vs 36). Hanall Biopharma leads on Sentiment (64 vs 45). The two are close on Growth and Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7009420001 | KR7002720001 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 30 | 43 |
| Value | 40 | 50 |
| Quality | 36 | 60 |
| Growth | 48 | 49 |
| Safety | 41 | 38 |
| Sentiment | 64 | 45 |
| Quality details | ||
| Profitability | 38 | 81 |
| Cash Truth | 34 | 38 |
Hanall Biopharma vs Ilsung ISHanall Biopharma vs Dongwha PharmHanall Biopharma vs Bora PharmaceuticalsHanall Biopharma vs Jeil PharmaAdd a third stock →
Full analyses: Hanall Biopharma · Kukje Pharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100